As a triple GLP-1/GIP/glucagon receptor agonist, it adds glucagon receptor activation on top of the dual mechanisms that tirzepatide already provides
Acetaminophen-induced hepatic necrosis
It first drew research interest for its ability to heal stomach ulcers and inflammatory bowel conditions, then expanded to tendon, ligament, muscle, and even bone healing across dozens of preclinical studies (Sikiric et al., PubMed)
Supplied in a standardized lyophilized (freeze-dried) powder format, it supports both small-scale and large-scale laboratory experiments
Clinical outcomes were assessed via the Total Nasal Symptom Score (TNSS), Sinonasal Outcome Test-22 (SNOT-22), and nasal endoscopy
Additional information Additional information Usage and disclaimer Intended solely for research purposes